- Published at
- by rttnews.com
neutral
neutral
Elicio Therapeutics Names Preetam Shah Chief Strategy And Financial Officer; Stock Down
Elicio Therapeutics, Inc. (ELTX), a clinical-stage biotechnology company, announced Monday the appointment of Preetam Shah as Chief Strategy and Financial Officer, effective as of the date hereof.